Anti-IgE and food allergy
- PMID: 39505277
- DOI: 10.1016/j.jaci.2024.10.020
Anti-IgE and food allergy
Abstract
Food allergy is a growing problem that can have a significant impact on both the individual, the family, and society. We are entering a new era of food allergy management with the recent US Food and Drug Administration approvals of 2 therapies for food allergy. IgE is now known to play a critical role in allergic diseases, including food allergy. Ant-IgE therapy has been under investigation for decades and is now approved for asthma, urticaria, nasal polyps, and most recently, IgE-mediated food allergy. Here, we evaluate what is known about the safety and efficacy of anti-IgE therapy as monotherapy and in combination with oral immunotherapy. In addition, we will highlight important practical considerations and key knowledge gaps.
Keywords: Food allergy; anti-IgE; treatment.
Copyright © 2024 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure statement Disclosure of potential conflict of interest: J. A. Dantzer receives research support from NIH. R. A. Wood receives research support from NIH, Aimmune, ALK, Aravax, DBV, Genentech, Novartis, and Siolta, and consulting fees from Genentech.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
